Send to a Friend Font Size: Increase Decrease

Pentwater Capital

Pentwater Capital

Pentwater Capital's Portfolio

Ticker	# of Shares	Price	Value
SGEN	9,629,500	$228.74	$2,202,651,830
ATVI	21,262,500	$94.42	$2,007,605,250
ATVI	21,116,300	$94.42	$1,993,801,046
HZNP	12,726,900	$116.30	$1,480,138,470
SPY	1,932,100	$672.38	$1,299,105,398
SGEN	5,634,900	$228.74	$1,288,927,026
	5,975,000	$195.32	$1,167,037,000
HZNP	9,900,000	$116.30	$1,151,370,000
	4,308,700	$195.32	$841,575,284
View Additional Portfolio Information »

A Chicago-based hedge fund launched in 2007 by manager Matthew Halbower. The fund specializes in merger arbitrage and event-driven investing.

Login to help us fill in information about this entity.

Form SCHEDULE 13D/A Poseida Therapeutics, Filed by: Pentwater Capital Management LP Jan 13, 2025 04:05PM

Form SC 13D/A Poseida Therapeutics, Filed by: Pentwater Capital Management LP Nov 27, 2024 07:02PM

Form SC 13D/A Poseida Therapeutics, Filed by: Pentwater Capital Management LP Apr 25, 2022 04:31PM

Form SC 13D Poseida Therapeutics, Filed by: Pentwater Capital Management LP Dec 28, 2020 04:05PM

Poseida Therapeutics (PSTX) Adds Luke Corning to Board Dec 17, 2020 08:12AM

Dec 17, 2020 08:00AM Poseida Therapeutics Appoints Luke Corning to Board of Directors